Pediatric Astrocytoma of the Cerebrum

Pediatric astrocytoma of the cerebrum is a type of brain tumor that starts from special support cells in the brain called astrocytes. These cells normally help nerve cells stay healthy. In this disease, some astrocytes start to grow in an abnormal and uncontrolled way and form a lump, or tumor, in the main part of the brain (the cerebrum). The tumor can be “low-grade” (slow growing) or “high-grade” (fast growing and more dangerous). Treatment is usually planned by a team of doctors and may include surgery, medicines like chemotherapy? or targeted therapy?, and radiation in some cases, plus strong supportive care and rehabilitation?. MDPI+1

Astrocytomas are a type of “glioma,” which means they come from glial cells, the helper cells of the brain and spinal cord?. Astrocytomas are the most common brain and spinal cord tumors in children and make up about half of all primary brain and spinal tumors in childhood. MSD Manuals+1

The cerebrum controls thinking, speech, movement, feeling, memory, and many other higher functions. When a tumor grows in this area, it can press on nearby brain tissue and disturb these important jobs, even if the tumor is “benign?” (non-cancerous) or slow-growing. Cancer.gov+1

Other Names

Pediatric astrocytoma of the cerebrum can also be called by several other names. These names may be used in medical reports, research papers, or hospital notes, but they all point to tumors made from astrocytes in the upper parts of a child’s brain. Cancer.gov+1

Other names include:

• Childhood cerebral astrocytoma – focuses on the tumor being in the main brain (cerebrum) of a child. The Journal of Neurosurgery+1

• Pediatric supratentorial astrocytoma – means the tumor is above the tentorium (the upper part of the brain), usually the cerebral hemispheres. Radiology Key+1

• Childhood hemispheric astrocytoma – used when the tumor is clearly in one or both brain hemispheres. The Journal of Neurosurgery+1

• Pediatric astrocytic tumor of the cerebrum – a broader term for any astrocyte tumor in the cerebrum in children. Cancer.gov+1

• Pediatric cerebral glioma (astrocytic type) – reminds us that astrocytoma is part of the glioma family. Cancer.gov+1

Types of Pediatric Astrocytoma of the Cerebrum

Doctors group these tumors by how the cells look under a microscope, how fast they grow, and where they sit in the brain. In children, low-grade (slow-growing) astrocytomas are more common than high-grade (fast-growing) ones, even in the cerebrum. Cancer.gov+1

Low-grade pilocytic astrocytoma (WHO grade I)
This is a slow-growing tumor that often has well-defined borders. Under the microscope, the cells look fairly close to normal astrocytes. Pilocytic astrocytomas in children often have a good outlook when they can be removed by surgery. Cancer.gov+1

Diffuse low-grade astrocytoma (pediatric-type, WHO grade II)
These tumors grow more into the nearby brain tissue and are less clearly separated from normal brain. They usually grow slowly but can sometimes change over time into higher-grade tumors. They are still considered low-grade, but careful follow-up is needed. Cancer.gov+1

Pediatric-type diffuse high-grade astrocytoma (anaplastic astrocytoma, glioblastoma)
These are fast-growing tumors with very abnormal cells. They can spread quickly within the brain and are harder to treat. In children, these high-grade gliomas often occur in the cerebral hemispheres and have a more serious outlook than low-grade tumors. Cancer.gov+1

Pleomorphic xanthoastrocytoma (PXA)
PXA is a rare astrocytoma that often appears in the outer parts of the cerebral hemispheres. It may cause seizures. Under the microscope, the tumor cells look very varied (“pleomorphic”), but many PXAs behave like low-grade tumors and can be treated well with complete surgery. Cancer.gov+1

Subependymal giant cell astrocytoma (SEGA)
SEGA is linked strongly with a genetic? disease called tuberous sclerosis? complex. It usually appears near the fluid spaces (ventricles?) of the brain, which are within the supratentorial region. It can block fluid flow and raise brain pressure but is often slow-growing. roswellpark.org+1

Other circumscribed astrocytic gliomas
Some astrocytomas in children are small, rounded, and more localized?, such as certain pediatric-type circumscribed astrocytic tumors. They may sit in the cerebral hemispheres and can often be cured by surgery when fully removed. Cancer.gov+1

Causes and Risk Factors

For most children with astrocytoma of the cerebrum, no clear cause can be found. Doctors believe many tumors arise from a mix of random gene changes and chance, not from something a parent or child did or did not do. Siteman Cancer Center+1

1. Unknown cause in most cases
   In the great majority of children with brain tumors, including cerebral astrocytoma, the exact cause is not known. Research shows that only a small share of cases are linked to inherited? conditions or known exposures. Siteman Cancer Center+1

2. General inherited genetic syndromes
   A small number of children have rare inherited disorders that raise the risk of brain tumors. These syndromes affect tumor-control genes in every cell, making it easier for tumors like astrocytomas to form. PMC+1

3. Neurofibromatosis type 1 (NF1)
   NF1 is a genetic condition that increases the chance of gliomas, including astrocytomas, in children. Children with NF1 need regular brain checks because they can develop optic pathway or other brain gliomas. roswellpark.org+1

4. Tuberous sclerosis complex (TSC)
   TSC causes non-cancerous tumors in many organs and increases the risk of subependymal giant cell astrocytoma in the brain. These tumors may sit in the supratentorial region and can cause hydrocephalus (fluid build-up). roswellpark.org+1

5. Li-Fraumeni syndrome?
   Li-Fraumeni is a rare syndrome caused by changes in the TP53 gene. It greatly raises the risk of many cancers, including brain tumors like astrocytomas in children and young adults. roswellpark.org+1

6. Other cancer-risk gene syndromes
   Other inherited syndromes such as neurofibromatosis type 2, von Hippel–Lindau disease, and some polyposis or DNA repair defects can also raise brain tumor risk. Together, these conditions explain a small part of pediatric brain tumors. ScienceDirect+1

7. Previous radiation therapy? to the head
   High-dose ionizing radiation to the head, given earlier in life to treat another disease, is a proven risk factor? for later brain tumors, including gliomas. This risk is real, but the life-saving benefits of radiation for the first cancer are usually greater. Cancer.org+1

8. High environmental ionizing radiation exposure
   Very high levels of ionizing radiation from accidents, certain medical uses, or the environment can damage DNA in brain cells and raise tumor risk. This is the best-known environmental risk factor for brain tumors in both adults and children. PMC+1

9. Family history? of brain tumors
   Some studies have found that having close relatives with brain tumors may slightly increase risk. This is likely due to shared genes or rare family syndromes, but for most families the increase in risk is still small. PMC+1

10. Older parental age at birth
    Research suggests that children born to older parents may have a somewhat higher risk of brain tumors. The exact reason is not clear, but may relate to age-linked genetic changes in egg or sperm cells. PMC+1

11. Parental occupational exposures
    Some older studies have looked at jobs where parents are exposed to certain chemicals, solvents, or radiation and found possible links with childhood astrocytoma. Evidence is mixed, and no single work exposure has been locked in as a clear cause. AACR Journals+1

12. Low birth weight? or prematurity
    Some population studies suggest that children who are very small at birth or born very early may have a slightly higher risk of certain brain tumors. Many factors can be involved, and the absolute risk is still low. PMC+1

13. Previous childhood cancer treatment
    Children who had chemotherapy and/or radiation for another cancer can, years later, develop second tumors in the brain. These “secondary” astrocytomas are treatment-related but still uncommon compared with the number of children cured. Cancer.gov+1

14. Random DNA changes in brain cells
    Even without known risk factors, cells in the brain can slowly collect DNA mistakes as a child grows. If key growth-control genes are damaged by chance, an astrocyte can start to divide too much and form a tumor. PMC+1

15. Specific tumor gene changes (for example, BRAF alterations)
    Many pediatric astrocytomas, especially low-grade ones, carry specific gene changes such as alterations in the BRAF gene. These are not usually inherited but happen only in the tumor and help drive its growth. Cancer.gov+1

16. Immune system problems
    Severe? problems with the immune system, whether inherited or acquired, may slightly raise the risk of certain brain tumors. The immune system normally helps find and remove abnormal cells, so when it is weak, tumors may grow more easily. PMC+1

17. General cancer-risk lifestyle factors (mainly in adults)
    In adults, some brain tumors are being studied for links to smoking, obesity, and other lifestyle factors. In children, these links are much less clear, and no strong direct lifestyle cause has been proven for pediatric astrocytoma. PMC+1

18. Allergy? and immune history
    Interestingly, some studies show people with strong allergy or atopy histories may have a slightly lower risk of glioma. This reminds us that immune system patterns can change brain tumor risk, though the exact relationship is complex. PMC

19. Head radiation from older medical tests
    In the past, children sometimes received higher doses of radiation to the head for minor problems (for example, ringworm of the scalp). This practice was later found to increase brain tumor risk and is no longer used. Cancer.org+1

20. Very high background radiation or nuclear accidents
    Living close to strong sources of radiation, such as nuclear accidents, can raise the risk of several cancers, including brain tumors. Thankfully, this is rare and affects only limited populations worldwide. PMC+1

Symptoms

Symptoms depend on tumor size, growth speed, and where in the cerebrum it sits. Some children have slowly increasing problems, while others may become sick more quickly if pressure in the skull? rises. Siteman Cancer Center+1

1. Headache? that gets worse over time
   A common sign is headache that becomes more frequent or more severe, often worse in the morning or when lying down. This happens because the tumor and swelling? can raise pressure inside the skull. Siteman Cancer Center+1

2. Nausea? and vomiting?
   Children may feel sick to the stomach or vomit, especially in the morning, even when they do not have a stomach illness. Raised brain pressure or irritation can trigger the vomiting center in the brain. Siteman Cancer Center+1

3. Seizures (fits)
   A tumor in the cerebrum can disturb normal electrical activity and cause seizures. Seizures may look like staring spells, shaking of part or all of the body, or sudden loss of awareness. MSD Manuals+1

4. Weakness? or clumsiness on one side of the body
   If the tumor presses on the motor areas of the brain, a child may develop weakness, stiffness?, or poor control in one arm or leg, or one side of the body. This may show as frequent falls or difficulty using one hand. Cancer.gov+1

5. Balance and walking problems
   Even though balance is mainly controlled by the cerebellum?, tumors in the cerebrum can still affect walking and coordination. The child may stagger, veer to one side, or have trouble with tasks like running or climbing stairs. Siteman Cancer Center+1

6. Vision changes
   Children can have blurred vision?, double vision, or loss of part of their visual field. Sometimes they may bump into objects or have trouble reading, as the tumor affects visual pathways or visual processing areas in the cerebrum. Siteman Cancer Center+1

7. Personality or behavior changes
   Tumors in the frontal or temporal lobes may change a child’s mood, behavior, or personality. Parents may notice irritability, sadness, anger, or changes in social behavior that are new or growing. Siteman Cancer Center+1

8. School and learning difficulties
   A child who was doing well in school may suddenly struggle with attention, memory, reading, or math. The tumor can disturb areas of the brain that handle thinking and learning. Siteman Cancer Center+1

9. Speech and language problems
   Tumors in language areas can cause trouble understanding speech or finding words. The child may speak more slowly, use wrong words, or seem unable to follow simple spoken instructions. Cancer.gov+1

10. Sleepiness or low energy
    Because of raised brain pressure or general sickness, children may feel very tired, sleep more than usual, or seem less interested in play and activities. Siteman Cancer Center+1

11. Head size increase in infants
    In babies whose skull bones have not yet joined, a growing brain tumor can cause the head to enlarge faster than normal. The soft spot (fontanelle) may bulge, and the scalp veins may look more prominent. Siteman Cancer Center+1

12. Irritability and crying in infants and toddlers
    Very young children may not be able to explain headaches or vision changes. Instead, they may be unusually fussy, cry more, or feed poorly because they feel unwell. Siteman Cancer Center+1

13. Hormone or growth problems
    If the tumor affects areas that connect with hormone centers, the child may show early or delayed puberty, growth problems, or changes in weight or appetite. This is more common when tumors are near the midline but can also affect cerebral functions. Cancer.gov+1

14. Abnormal eye movements
    Some children may have shaking eyes (nystagmus) or eyes that do not move together. This can result from increased pressure or involvement of brain pathways that control eye movement. Siteman Cancer Center+1

15. Sudden severe headache with confusion or drowsiness
    Very rarely, bleeding into the tumor or a sudden sharp rise in pressure can cause sudden, very strong headache with confusion, drowsiness, or even coma. This is an emergency. Siteman Cancer Center+1

Diagnostic Tests for Pediatric Astrocytoma of the Cerebrum

Doctors use a mix of physical exam, manual bedside tests, lab and pathology tests, electrodiagnostic studies, and imaging to diagnose and understand these tumors. Usually, MRI brain imaging and a tumor biopsy are key parts of diagnosis, guided by the child’s symptoms and overall condition. Cancer.gov+1

Physical Exam Tests

1. General physical and neurological exam
   The doctor checks the child’s overall health, development, and nervous system. They look at strength, reflexes, sensation, balance, and coordination to see which parts of the brain may be affected. Siteman Cancer Center+1

2. Vital signs and level of consciousness
   Blood pressure, heart rate, breathing, and temperature are measured, and the doctor checks how awake and alert the child is. Changes in these signs can suggest raised pressure in the brain or serious illness. Siteman Cancer Center+1

3. Head size measurement in infants and young children
   For babies and toddlers, the doctor measures head circumference and compares it with growth charts. A head that grows too fast or is much larger than expected can suggest increased pressure from a tumor or other brain problem. Siteman Cancer Center+1

4. Eye and optic nerve exam (fundoscopy)
   Using a special light, the doctor looks at the back of the eyes to see the optic nerve. Swelling of the optic disc (papilledema) can show high pressure inside the skull, which may be caused by a brain tumor. Siteman Cancer Center+1

Manual Bedside Tests

5. Muscle strength testing
   The child is asked to push and pull with arms and legs against resistance. Differences in strength between sides help locate areas of the cerebrum that may be affected by the tumor. Siteman Cancer Center+1

6. Coordination tests (finger-to-nose, heel-to-shin)
   The doctor asks the child to touch their nose then the examiner’s finger, or to slide the heel down the opposite shin. Clumsy or inaccurate movements can point to problems with the brain areas that control movement planning. Siteman Cancer Center+1

7. Gait and balance tests (walking, heel-to-toe)
   The child may be asked to walk normally, on heels, on toes, or in a straight line. Difficulty walking straight or frequent loss of balance can suggest cerebrum or cerebellum involvement. Siteman Cancer Center+1

8. Simple mental and language tests
   Doctors may ask the child to remember words, name objects, follow commands, or do simple calculations. Trouble with these tasks can show problems in memory, attention, or language areas of the cerebrum. Cancer.gov+1

Lab and Pathological Tests

9. Complete blood count and basic blood tests
   Blood tests help check the child’s overall health, look for infection or anemia, and prepare for surgery or other treatments. While they do not diagnose the tumor directly, they support safe care. Cancer.gov+1

10. Blood chemistry and hormone tests (when needed)
    Tests of salts, kidney and liver function, and sometimes hormones help show how the body is coping. If hormone problems are suspected, extra tests can guide diagnosis and treatment planning. Cancer.gov+1

11. Lumbar puncture (spinal tap) for cerebrospinal fluid (CSF)
    In some cases, doctors take a small sample of the fluid around the brain and spinal cord by placing a needle into the lower back. The fluid is checked for tumor cells, infection, or other changes. This test is done carefully and not when pressure is very high. Cancer.gov+1

12. Surgical biopsy of the brain tumor
    A neurosurgeon removes a small piece, or sometimes all, of the tumor. The sample is sent to a pathology lab where experts look at the cells and decide the tumor type and grade. This is the most important step to confirm astrocytoma. Cancer.gov+1

13. Molecular and genetic testing of tumor tissue
    Modern care often includes tests on the tumor sample to look for gene changes such as BRAF alterations or other markers. These tests help refine the diagnosis and may guide targeted treatments in some children. Cancer.gov+1

Electrodiagnostic Tests

14. Electroencephalogram (EEG)
    EEG records the brain’s electrical activity using small stickers on the scalp. It is especially useful when seizures are present, helping doctors see where in the brain the abnormal activity starts and how severe it is. MSD Manuals+1

15. Visual evoked potentials (VEPs)
    In this test, the child looks at flashing lights or patterns while electrodes on the head record brain responses. It helps measure how well visual signals travel from the eyes to the brain, which can be affected by tumors in or near visual pathways. Cancer.gov+1

16. Auditory (hearing) evoked responses
    Sounds are played in the child’s ears while brain responses are recorded. If signals travel slowly or not at all, it may suggest a problem along the hearing pathways, which sometimes helps with overall brain tumor assessment. Cancer.gov+1

Imaging Tests

17. Magnetic resonance imaging (MRI) of the brain with contrast
    MRI uses strong magnets and radio waves to make detailed pictures of the brain. With contrast dye, it shows the size, location, and features of the tumor very clearly and is the main imaging test for pediatric astrocytoma of the cerebrum. Cancer.gov+1

18. Computed tomography (CT) scan of the head
    CT uses X-rays to create quick images of the brain and is helpful in emergencies or when MRI is not available. It can show bleeding, calcification, or large masses but gives less detail than MRI and uses radiation. Cancer.gov+1

19. Advanced MRI techniques (perfusion, diffusion, spectroscopy)
    Special MRI methods can measure blood flow, water movement, and chemical patterns in the tumor and surrounding brain. These added details can help tell tumor tissue from swelling and may help in planning surgery or other treatments. Cancer.gov+1

20. Positron emission tomography (PET) or PET-CT
    PET scans use a small amount of radioactive sugar to show how active different brain areas are. High-grade tumors may show higher uptake. When combined with CT or MRI, PET can help distinguish active tumor from scar tissue in some cases. Cancer.gov+1

Non-pharmacological treatments and supportive therapies

Here are key non-drug treatments often used along with medical therapy. Evidence mainly shows benefit for quality of life, strength, thinking skills, and emotional health, not that they shrink the tumor. PMC+3PMC+3OUP Academic+3

1. Physical therapy (PT)
Physical therapy uses safe exercises, stretching, and balance training to help the child move better, stay strong, and prevent stiffness. The therapist slowly increases activity to match the child’s energy level during and after treatment. The purpose is to keep muscles and joints working well and to lower the risk of contractures and falls. The main mechanism is repeated, guided movement that retrains brain and muscles to work together and helps the nervous system adapt after surgery or treatment.

2. Occupational therapy (OT)
Occupational therapy helps the child do daily tasks like dressing, eating, writing, and playing. The therapist may suggest special tools, different ways to sit, or simpler steps for complex tasks. The purpose is to keep the child as independent as possible at home and school. The mechanism is “task-specific practice,” which means the child repeats real-life activities in a safe way so the brain can build new pathways and compensate for weak or damaged areas.

3. Speech and language therapy
Some children with cerebral astrocytoma have problems speaking, understanding words, or swallowing. A speech-language therapist (SLT) uses exercises for lips, tongue, voice, and breathing, and may teach picture or device-based communication. The purpose is to improve safe swallowing, clear speech, and communication with family and teachers. The mechanism is repeated practice and feedback to strengthen the muscles and reorganize language areas of the brain. SAGE Journals+1

4. Neurocognitive rehabilitation
This therapy focuses on attention, memory, school skills, and problem-solving. A psychologist or neuropsychologist tests the child and then designs games, computer tasks, and paper exercises to train weak areas. The purpose is to reduce “chemo brain” or cognitive late effects and support school performance. The mechanism is called neuroplasticity: the brain adapts when tasks are repeated, so new neural pathways can partly replace damaged ones. PMC+1

5. Psychological counseling and family support
A brain tumor diagnosis is very stressful for the child and family. Psychologists, social workers, or counselors offer regular talking sessions, coping skills, and crisis support. The purpose is to lower anxiety, depression, and fear, and to help parents manage stress and decisions. The mechanism is emotional processing, learning coping strategies, and improving family communication, which can also help the child follow treatment plans better. MDPI

6. School reintegration and educational support
Many children miss school or return with learning or fatigue problems. A school liaison or hospital teacher works with the local school to adjust workload, give extra time in exams, or provide home tutoring. The purpose is to keep education on track and reduce social isolation. The mechanism is practical changes in the school setting that match the child’s cognitive and physical abilities while they heal. PM&R KnowledgeNow+1

7. Structured exercise and physical activity programs
Supervised exercise programs include walking, cycling, stretching, and light strength training. These are carefully adjusted to the child’s heart and lung status and treatment stage. The purpose is to improve physical fitness, reduce fatigue, and support mental health. Studies show that exercise is usually safe and can improve quality of life in pediatric cancer survivors when done under supervision. The mechanism is improved blood flow, muscle strength, and hormone balance, which together support the child’s recovery. PMC+1

8. Nutrition counseling
A dietitian checks weight, growth, and lab tests and helps plan meals with enough calories, protein, vitamins, and fluids. The purpose is to prevent malnutrition, manage nausea or poor appetite, and support immune function. The mechanism is simple: when the body gets the right nutrients, it can repair tissues better, tolerate treatment, and fight infections more effectively. OUP Academic+1

9. Pain management with non-drug methods
Besides medicines, children can use heat or cold packs, gentle massage, relaxation breathing, distraction with games or music, and comfortable positioning. The purpose is to reduce pain from surgery, stiffness, or procedures. The mechanism mixes physical effects (less muscle spasm, better blood flow) and brain effects (shifting attention away from pain and lowering stress signals).

10. Complementary mind–body therapies (used only with medical approval)
Some centers offer relaxation training, mindfulness, guided imagery, or gentle yoga adapted to the child’s abilities. The purpose is to reduce stress, sleep problems, and fear during treatment. The mechanism involves calming the autonomic nervous system, lowering heart rate and stress hormones, and helping the child feel more in control. These therapies should always be supervised and never replace standard tumor treatment. MDPI+1

Drug treatments

Drug treatment for pediatric astrocytoma of the cerebrum depends on tumor grade, location, gene changes (such as BRAF mutations), and how much of the tumor can be removed safely. Below are examples of important drug classes used in pediatric low-grade glioma and related brain tumors. Exact drugs, combinations, and doses must follow full FDA labels and specialized pediatric protocols. PMC+2ClinicalTrials.gov+2

Platinum chemotherapy – carboplatin
Carboplatin is a chemotherapy drug often used with vincristine for low-grade gliomas in children. It damages DNA inside tumor cells, so they cannot divide and eventually die. It is given by vein in cycles under strict monitoring. The purpose is to control or shrink tumors that cannot be fully removed by surgery or that grow again. Common side effects include low blood counts, infection risk, nausea, and hearing problems. Its use is guided by FDA labeling for carboplatin injection and pediatric oncology protocols, and dosing is calculated by experts, not at home. PMC+3FDA Access Data+3FDA Access Data+3

Vinca alkaloid chemotherapy – vincristine
Vincristine is a drug that blocks microtubules, which are tiny structures cells need to divide. It is a key part of many pediatric brain tumor regimens, including carboplatin–vincristine combinations. Vincristine is given only by IV in a hospital or clinic; if given by the wrong route it can be fatal, so safety rules are very strict in the FDA label. Major side effects include nerve damage (weakness, numbness), constipation, and low blood counts. The purpose is to slow or stop tumor cell growth. Dose and schedule are chosen by pediatric oncologists following official labeling and protocols. PMC+3FDA Access Data+3FDA Access Data+3

Alkylating agent – temozolomide
Temozolomide is an oral chemotherapy that turns into an active form in the body and adds damage to tumor DNA. It is commonly used in high-grade gliomas and sometimes in recurrent low-grade tumors. The purpose is to shrink or control the tumor after surgery or radiation. Side effects can include low blood counts, nausea, tiredness, and risk of infection. Dosing usually uses cycles (days on drug, days off) and follows FDA guidance and clinical trials; it must be supervised by experienced doctors. PMC+1

Nitrosoureas – lomustine and related agents
Lomustine (CCNU) and similar drugs are older chemotherapies that cross the blood–brain barrier and damage DNA. They are sometimes used in combination regimens for recurrent or high-grade brain tumors. The purpose is to provide an extra line of attack when standard regimens are not enough. Side effects include long-lasting low blood counts, nausea, and risk of lung or liver toxicity. Because of these risks, dosing is very carefully planned and spaced out in time. PMC+1

Multi-drug regimens (TPCV and others)
Some protocols for pediatric astrocytoma or low-grade glioma use combinations like thioguanine, procarbazine, lomustine, and vincristine (TPCV) or other multi-drug regimens. These combinations attack the tumor at different cell-cycle points to improve control. The purpose is to delay or avoid radiation in young children by using chemotherapy instead. Side effects are more complex and can include bone marrow suppression, liver toxicity, and infertility risks, so these regimens are used only in specialized centers. PMC+2ClinicalTrials.gov+2

Targeted therapy – dabrafenib
Dabrafenib is a targeted therapy that blocks BRAF V600E, a specific gene mutation seen in some pediatric low-grade gliomas. In 2023, the FDA approved dabrafenib plus trametinib for children 1 year and older with low-grade glioma and a BRAF V600E mutation who need systemic therapy. It is taken by mouth in capsules or pediatric formulations. The purpose is to slow tumor growth by directly blocking the faulty signaling pathway. Side effects can include fever, skin problems, joint pain, and effects on heart or eyes, so monitoring is needed. AACR Journals+3U.S. Food and Drug Administration+3PMC+3

Targeted therapy – trametinib
Trametinib is a MEK inhibitor that works in the same signaling pathway as BRAF. When combined with dabrafenib, it provides a stronger block of the pathway in BRAF-mutant tumors. The FDA approval for dabrafenib plus trametinib in pediatric low-grade glioma is based on improved response and progression-free survival compared with traditional carboplatin–vincristine therapy. The purpose is to offer a more precise treatment with potential for fewer long-term toxicities. Side effects include rash, diarrhea, heart and eye effects, and must be checked regularly. AACR Journals+3U.S. Food and Drug Administration+3PMC+3

mTOR inhibitor – everolimus (selected cases)
Everolimus is a targeted drug that blocks mTOR, a protein involved in cell growth. It is approved for certain brain tumors like subependymal giant cell astrocytoma in tuberous sclerosis, which is related to astrocytic tumors. In selected children, it may help shrink or stabilize tumors that cannot be removed. The purpose is to control growth by blocking an overactive growth pathway. Side effects include mouth sores, infections, high cholesterol, and effects on kidney function. Dosing is individualized with blood-level monitoring. MDPI

Monoclonal antibody – bevacizumab (selected indications)
Bevacizumab is an antibody that blocks VEGF, a signal that helps form new blood vessels. It is sometimes used off-label in children with recurrent brain tumors or significant radiation-related swelling. The purpose is to reduce edema, improve symptoms, and sometimes shrink enhancing tumor or radiation necrosis. Side effects include high blood pressure, bleeding, poor wound healing, and kidney problems, so it is used carefully. MDPI+1

Immunotherapy – pembrolizumab in special cases
Pembrolizumab is a PD-1 immune checkpoint inhibitor. It is FDA-approved for several cancers and some tumors with high microsatellite instability or high mutation burden. In rare selected pediatric brain tumor cases with these features, immunotherapy may be considered. The purpose is to “unblock” the immune system so it can recognize and attack tumor cells. Side effects include immune-related inflammation of organs like lungs, liver, colon, and glands, so it requires very close supervision. FDA Access Data+1

(Other chemotherapies like cisplatin, cyclophosphamide, etoposide, and irinotecan may also be used in specialized protocols, but listing all in detail is beyond this overview. All must follow full FDA labeling and expert protocols.) MDPI+1

Dietary molecular supplements and nutrition support

No vitamin, herb, or supplement has been proven to cure pediatric astrocytoma of the cerebrum. Supplements are only used to correct deficiencies or support general health, and must always be checked with the oncology team because some can interfere with chemotherapy. OUP Academic+1

Balanced protein and calorie supplements
Liquid or powdered nutritional drinks can give extra calories and high-quality protein when a child cannot eat enough. The purpose is to prevent weight loss and muscle breakdown. The mechanism is simple: extra protein supports tissue repair and immune cells, and extra calories prevent the body from burning its own muscle for energy. Dose and brand are chosen by the dietitian based on age, kidney function, and appetite.

Vitamin D and calcium (if deficient)
Children who stay indoors, receive steroids, or have reduced intake can develop weak bones. Vitamin D and calcium supplements can support bone health when tests show low levels. The purpose is to prevent fractures and bone pain. The mechanism is improved calcium absorption and stronger bone mineralization. The dose should follow pediatric guidelines and lab values, not home guessing. OUP Academic

Omega-3 fatty acids (fish oil) – with medical approval
Omega-3 fatty acids may help reduce inflammation and support heart and brain health. In some pediatric cancer survivors, they are considered when diet is poor. The purpose is general health support, not tumor control. The mechanism involves changing cell-membrane fats and signaling molecules. However, omega-3 can increase bleeding risk, so oncologists must approve and set safe doses.

Probiotics – in carefully selected children
Probiotics are “good bacteria” that may help gut health. In some cases, they can reduce antibiotic-related diarrhea. The mechanism is restoring a healthy gut microbiome. However, children with very low immune function should be very cautious, because live bacteria can rarely cause infection in severely immunocompromised patients. Only the oncology team should decide if probiotics are safe. OUP Academic

Multivitamins (low-dose)
Simple, low-dose multivitamins may be used when diet is limited. The purpose is to avoid mild deficiency of vitamins like B-complex, vitamin C, and trace minerals. The mechanism is providing small amounts of many nutrients that act as helpers in cell reactions. High-dose “megavitamin” therapy is not recommended because it can interact with chemo and may be unsafe.

Immune support and regenerative or stem-cell-related treatments

There are no simple “immunity booster” or stem cell pills for pediatric astrocytoma. Instead, doctors use medical tools to support bone marrow and, in rare cases, perform stem cell transplantation. MDPI+1

Granulocyte colony-stimulating factor (G-CSF, e.g., filgrastim)
G-CSF is a drug that tells the bone marrow to make more white blood cells after chemotherapy. The purpose is to shorten the time of low white cell counts and reduce infection risk. The mechanism is binding to receptors on marrow cells to speed up neutrophil production. It is given by injection with dosing strictly set by body weight and lab counts.

Pegylated G-CSF (pegfilgrastim)
Pegfilgrastim is a long-acting version of G-CSF. One injection after a chemo cycle can cover many days. The purpose and mechanism are similar to filgrastim, but the drug stays longer in the body. Side effects can include bone pain. Oncologists decide if and when to use it in children.

Erythropoiesis-stimulating agents (ESAs, e.g., epoetin alfa)
ESAs are drugs that stimulate the bone marrow to make more red blood cells. The purpose is to reduce anemia-related fatigue when appropriate, although they are used less now because of safety concerns in some cancers. The mechanism is mimicking natural erythropoietin hormone. Their use is very carefully weighed in pediatric oncology. MDPI+1

Intravenous immunoglobulin (IVIG)
IVIG is a purified antibody product given by vein. In selected children with low antibody levels or certain immune complications, IVIG may be used to help prevent or treat infections. The mechanism is providing ready-made antibodies from healthy donors. It is not a tumor treatment but can support immune defense.

Autologous stem cell collection and transplant (in special high-risk cases)
For some very aggressive brain tumors, not usually typical low-grade astrocytoma, doctors may use high-dose chemotherapy followed by the child’s own stem cells (autologous transplant). The purpose is to allow stronger chemotherapy than the bone marrow could otherwise tolerate. The mechanism is that stored stem cells are returned after treatment to re-grow the bone marrow. This procedure is complex and only done in specialized centers. MDPI+1

Surgeries for pediatric cerebral astrocytoma

Surgical removal (tumor resection)
The main surgery is to remove as much of the tumor as safely possible. A neurosurgeon uses advanced brain imaging and sometimes navigation systems to guide the operation. The purpose is to lower tumor burden and relieve pressure on brain tissue. The mechanism is purely mechanical: cutting out tumor tissue while protecting critical areas for movement, speech, and vision. MDPI+1

Biopsy
If the tumor cannot be safely removed, surgeons may take a small tissue sample (biopsy) using a needle or small opening. The purpose is to confirm the exact type and grade of astrocytoma and to test for gene changes like BRAF. The mechanism is getting real tumor cells for the pathologist and molecular lab to study under a microscope and with special tests.

CSF diversion (shunt or endoscopic third ventriculostomy)
If the tumor blocks the normal flow of brain fluid and causes hydrocephalus, surgeons may place a shunt (a small tube) or make a new fluid pathway with a scope. The purpose is to lower pressure in the brain, reduce headaches, and protect vision and consciousness. The mechanism is redirecting cerebrospinal fluid to another body space where it can be absorbed. MDPI+1

Second-look or debulking surgery
Sometimes, after chemotherapy or targeted therapy, a second surgery is done to remove more tumor that has shrunk or become easier to reach. The purpose is to improve long-term control and reduce the amount of tumor left in the brain.

Palliative neurosurgical procedures
In selected cases when cure is not possible, smaller procedures may be done to relieve symptoms, such as reducing pressure or removing a part of tumor causing severe seizures. The purpose is comfort and better quality of life. MDPI+1

Prevention and risk reduction

There is no known way to fully prevent pediatric astrocytoma of the cerebrum, because many cases start from gene changes we cannot control. However, some general points are important: MDPI+1

1. Avoid unnecessary radiation to the head – Medical imaging like CT scans should be used only when truly needed.

2. Manage genetic syndromes – Children with conditions like neurofibromatosis type 1 need regular follow-up, so tumors can be caught early if they occur.

3. Healthy pregnancy and early life care – Good prenatal care and avoiding harmful substances in pregnancy support overall brain health, though this does not guarantee prevention.

4. Prompt evaluation of persistent symptoms – Early medical checks for chronic headaches, repeated vomiting, or new neurological symptoms can lead to earlier diagnosis.

5. Complete vaccinations and infection control – These protect overall health during treatment if a tumor occurs.

When to see doctors

Parents or caregivers should take a child to a doctor as soon as possible if they notice: MDPI+1

• Frequent or worsening headaches, especially morning headaches

• Repeated vomiting without clear stomach illness

• New seizures or fits

• Sudden problems with balance, walking, or weakness in an arm or leg

• Changes in behavior, school performance, or personality that are not explained by stress alone

• Vision problems like blurred or double vision

• Any sudden change in consciousness, drowsiness, or confusion

If a child already has a diagnosed astrocytoma, contact the oncology team urgently for:

• Fever, signs of infection, or bleeding

• Strong headache with stiff neck or new vomiting

• Sudden weakness or seizures

• Any side effect from chemotherapy or targeted therapy that seems severe or unusual

What to eat and what to avoid

What to eat (with dietitian and doctor advice) OUP Academic+1

1. Balanced meals with fruits, vegetables, whole grains, and lean proteins (fish, chicken, eggs, beans).

2. Enough calories to keep weight stable, with snacks like yogurt, nut butters, or smoothies if appetite is low.

3. Adequate protein to help repair tissues and support immune cells.

4. Plenty of fluids, mainly water, to prevent dehydration and help kidneys handle chemotherapy.

5. Foods rich in fiber (fruits, vegetables, whole grains) to reduce constipation from medicines like vincristine.

What to avoid or limit

1. Raw or undercooked meat, eggs, and fish when blood counts are low, to reduce infection risk.

2. Unpasteurized milk or juices and unsafe street foods.

3. Herbal supplements or “miracle cures” without oncologist approval, because they may interact with treatment.

4. Very high sugar drinks and junk food; they add calories but no nutrients and may worsen fatigue.

5. Energy drinks and high-caffeine products, which can affect heart rate, sleep, and hydration.

Frequently asked questions (FAQs)

1. Is pediatric astrocytoma of the cerebrum always cancer?
Astrocytoma is a type of brain tumor. Some astrocytomas are low-grade and grow slowly; others are high-grade and more aggressive. Doctors still treat both very seriously because they grow inside the brain, which is a delicate area. MDPI+1

2. Can this tumor spread to other parts of the body?
Most pediatric astrocytomas stay within the brain or spinal cord. Some higher-grade tumors can spread within the brain and along the spinal fluid pathways, but spread to organs outside the nervous system is rare.

3. Is surgery always needed?
If the tumor can be safely reached, surgeons usually try to remove as much as possible, because this improves control and sometimes cure rates in low-grade tumors. If surgery would cause major damage, doctors may choose only a biopsy plus medicines. MDPI+1

4. Will my child need radiation therapy?
Radiation therapy may be used for certain tumors, especially higher-grade or recurrent ones. In young children, doctors often try to delay or avoid radiation by using chemotherapy, because radiation can affect brain development. The choice depends on age, tumor type, and previous treatments. MDPI

5. Are targeted therapies safer than chemotherapy?
Targeted drugs like dabrafenib and trametinib were developed to act mainly on cells with specific gene changes such as BRAF V600E. They can offer better tumor control with a different side-effect profile, but they still have important risks and require close monitoring. They are not “side-effect-free.” U.S. Food and Drug Administration+2PMC+2

6. How long will treatment last?
Treatment length varies widely. Some children have surgery and close follow-up only. Others may need months to years of chemotherapy or targeted therapy, plus long-term rehabilitation and monitoring. The oncology team gives a plan tailored to the child’s situation. MDPI+1

7. Will my child be able to go back to school?
Many children do return to school, sometimes with special supports like reduced hours, extra time for tests, or a classroom assistant. Neurocognitive testing and rehabilitation can help plan the best learning environment.

8. What are late effects of treatment?
Late effects can include learning problems, hormonal changes, growth delays, hearing loss, and emotional issues. That is why long-term follow-up in survivorship clinics is important. Early detection and therapy can reduce impact. MDPI+2PM&R KnowledgeNow+2

9. Are there clinical trials for pediatric cerebral astrocytoma?
Yes. Clinical trials may test new drug combinations, targeted therapies, or supportive care strategies. The oncology team can discuss whether a trial is suitable for a child based on tumor features and previous treatments. PMC+2ClinicalTrials.gov+2

10. Can food or supplements cure the tumor?
No. At this time, there is no food or supplement that can cure pediatric astrocytoma. Good nutrition supports strength and healing, but only surgery, radiation, chemotherapy, and targeted therapies have proven tumor-control effects. OUP Academic+1

11. Does stress cause this tumor?
There is no strong evidence that emotional stress alone causes astrocytoma. It is usually related to gene and cell changes that we do not fully understand. However, reducing stress is still helpful for coping and recovery.

12. Will my other children be at higher risk?
In most cases, astrocytoma is not clearly inherited. If a child has a known genetic syndrome, such as neurofibromatosis, relatives may need genetic counseling. Otherwise, the risk to siblings is usually low. MDPI

13. How often will my child need MRI scans?
MRI scans are used to check how the tumor is responding and to look for recurrence. At first, scans may be every few months; over time, they may be less frequent. The exact schedule depends on tumor grade, treatment, and how stable the scans are. MDPI+1

14. Can my child play sports?
Many children can do light to moderate activity when their doctors say it is safe. Contact sports or activities with high risk of head injury may need to be limited, especially after surgery or with shunts. The rehabilitation and oncology team will give personalized advice. PMC+1

15. Where can families find support?
Families can seek support from hospital social workers, local and online brain tumor support groups, psychological services, and school counselors. These resources can help with emotional coping, practical issues, and connection with other families facing similar challenges. MDPI

Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical  history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.

The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members

Last Updated: December 31, 2025.